OpenURL Connection Search

Select item for more details and to access through your institution.

Predicting Sustained Clinical Response to Rituximab in Moderate to Severe Systemic Manifestations of Primary Sjögren Syndrome.
Published in:
ACR Open Rheumatology, 2022, v. 4, n. 8, p. 689, doi. 10.1002/acr2.11466
By:
- Pepple, Sophanit;
- Arnold, Jack;
- Vital, Edward M.;
- Rawstron, Andrew C.;
- Pease, Colin T.;
- Dass, Shouvik;
- Emery, Paul;
- Md Yusof, Md Yuzaiful
Publication type:
Article
A Personalized Rituximab Retreatment Approach Based on Clinical and B-Cell Biomarkers in ANCA-Associated Vasculitis.
Published in:
Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2021.803175
By:
- Arnold, Jack;
- Vital, Edward M.;
- Dass, Shouvik;
- Aslam, Aamir;
- Rawstron, Andy C.;
- Savic, Sinisa;
- Emery, Paul;
- Md Yusof, Md Yuzaiful
Publication type:
Article
Autologous stem cell transplantation in chronic myeloid leukaemia using Philadelphia chromosome negative blood progenitors mobilised with hydroxyurea and G-CSF.
Published in:
Bone Marrow Transplantation, 1998, v. 21, n. 5, p. 455, doi. 10.1038/sj.bmt.1701118
By:
- Pratt, G;
- Johnson, R J;
- Rawstron, A C;
- Barnard, D L;
- Morgan, G J;
- Smith, G M
Publication type:
Article
Eradication of minimal residual disease improves overall and progression-free survival in patients with chronic lymphocytic leukaemia, evidence from NCRN CLL207: a phase II trial assessing alemtuzumab consolidation.
Published in:
British Journal of Haematology, 2017, v. 176, n. 4, p. 573, doi. 10.1111/bjh.14342
By:
- Varghese, Abraham M.;
- Howard, Dena R.;
- Pocock, Christopher;
- Rawstron, Andy C.;
- Follows, George;
- McCarthy, Helen;
- Dearden, Claire;
- Fegan, Christopher;
- Milligan, Donald;
- Smith, Alexandra F.;
- Gregory, Walter;
- Hillmen, Peter
Publication type:
Article
Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism.
Published in:
Oncogene, 2003, v. 22, n. 7, p. 1103, doi. 10.1038/sj.onc.1206335
By:
- Fenton, James A L;
- Pratt, Guy;
- Rawstron, Andy C;
- Sibley, Kathryn;
- Rothwell, Dominic;
- Yates, Zoe;
- Dring, Ann;
- Richards, Steve J;
- Ashcroft, A John;
- Davies, Faith E;
- Owen, Roger G;
- Child, J Anthony;
- Morgan, Gareth J
Publication type:
Article
Reproducible diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA) Harmonisation project.
Published in:
Cytometry. Part B, 2018, v. 94, n. 1, p. 121, doi. 10.1002/cyto.b.21595
By:
- Rawstron, Andy C.;
- Kreuzer, Karl‐Anton;
- Soosapilla, Asha;
- Spacek, Martin;
- Stehlikova, Olga;
- Gambell, Peter;
- McIver‐Brown, Neil;
- Villamor, Neus;
- Psarra, Katherina;
- Arroz, Maria;
- Milani, Raffaella;
- de la Serna, Javier;
- Cedena, M. Teresa;
- Jaksic, Ozren;
- Nomdedeu, Josep;
- Moreno, Carol;
- Rigolin, Gian Matteo;
- Cuneo, Antonio;
- Johansen, Preben;
- Johnsen, Hans E.
Publication type:
Article
Measuring disease levels in myeloma using flow cytometry in combination with other laboratory techniques: Lessons from the past 20 years at the Leeds Haematological Malignancy Diagnostic Service.
Published in:
Cytometry. Part B, 2016, v. 90, n. 1, p. 54, doi. 10.1002/cyto.b.21271
By:
- Rawstron, Andy C.;
- de Tute, Ruth M.;
- Haughton, J.;
- Owen, Roger G.
Publication type:
Article
Assessment of minimal residual disease in myeloma and the need for a consensus approach.
Published in:
Cytometry. Part B, 2016, v. 90, n. 1, p. 21, doi. 10.1002/cyto.b.21272
By:
- Rawstron, Andy C.;
- Paiva, Bruno;
- Stetler‐Stevenson, Maryalice
Publication type:
Article
Consensus guidelines on plasma cell myeloma minimal residual disease analysis and reporting.
Published in:
Cytometry. Part B, 2016, v. 90, n. 1, p. 31, doi. 10.1002/cyto.b.21228
By:
- Arroz, Maria;
- Came, Neil;
- Lin, Pei;
- Chen, Weina;
- Yuan, Constance;
- Lagoo, Anand;
- Monreal, Mariela;
- de Tute, Ruth;
- Vergilio, Jo‐Anne;
- Rawstron, Andy C.;
- Paiva, Bruno
Publication type:
Article
Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition.
Published in:
Cytometry. Part B, 2016, v. 90, n. 1, p. 26, doi. 10.1002/cyto.b.21249
By:
- Stetler‐Stevenson, Maryalice;
- Paiva, Bruno;
- Stoolman, Lloyd;
- Lin, Pei;
- Jorgensen, Jeffrey L.;
- Orfao, Alberto;
- Van Dongen, Jacques;
- Rawstron, Andy C.
Publication type:
Article
Assessment of Bone Marrow Response in Waldenström's Macroglobulinemia.
Published in:
Clinical Lymphoma & Myeloma, 2009, v. 9, n. 1, p. 53
By:
- Varghese, Abraham M.;
- Rawstron, Andy C.;
- Ashcroft, A. John;
- Moreton, Paul;
- Owen, Roger G.
Publication type:
Article
Immunoglobulin Heavy Chain Sequence Analysis in Waldenström's Macroglobulinemia and Immunoglobulin M Monoclonal Gammopathy of Undetermined Significance.
Published in:
Clinical Lymphoma & Myeloma, 2006, v. 7, n. 1, p. 70
By:
- Rollett, Rebecca A.;
- Wilkinson, Elizabeth J.;
- Gonzalez, David;
- Fenton, James A. L.;
- Short, Michael A.;
- Evans, Paul A. S.;
- Rawstron, Andy C.;
- Owen, Roger G.
Publication type:
Article
Immunoglobulin M Concentration in Waldenström Macroglobulinemia: Correlation With Bone Marrow B Cells and Plasma Cells.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2013, v. 13, n. 2, p. 211, doi. 10.1016/j.clml.2013.02.018
By:
- De Tute, Ruth M.;
- Rawstron, Andy C.;
- Owen, Roger G.
Publication type:
Article
Heterogeneity of Histological Transformation Events in Waldenström’s Macroglobulinemia (WM) and Related Disorders.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 1, p. 176, doi. 10.3816/CLML.2011.n.042
By:
- Owen, R. G.;
- Bynoe, A. G.;
- Varghese, A.;
- de Tute, R. M.;
- Rawstron, A. C.
Publication type:
Article
Occult B-cell lymphoproliferative disorders.
Published in:
Histopathology, 2011, v. 58, n. 1, p. 81, doi. 10.1111/j.1365-2559.2010.03702.x
By:
- Rawstron, Andy C
Publication type:
Article
Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab.
Published in:
Rheumatology, 2008, v. 47, n. 4, p. 552
By:
- D. McGonagle;
- A. L. Tan;
- J. Madden;
- A. C. Rawstron;
- A. Rehman;
- P. Emery;
- S. Thomas
Publication type:
Article
Improving efficiency and sensitivity: European Research Initiative in CLL (ERIC) update on the international harmonised approach for flow cytometric residual disease monitoring in CLL.
Published in:
Leukemia (08876924), 2013, v. 27, n. 1, p. 142, doi. 10.1038/leu.2012.216
By:
- Rawstron, A C;
- Böttcher, S;
- Letestu, R;
- Villamor, N;
- Fazi, C;
- Kartsios, H;
- de Tute, R M;
- Shingles, J;
- Ritgen, M;
- Moreno, C;
- Lin, K;
- Pettitt, A R;
- Kneba, M;
- Montserrat, E;
- Cymbalista, F;
- Hallek, M;
- Hillmen, P;
- Ghia, P
Publication type:
Article
Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management.
Published in:
2010
By:
- Shanafelt, T D;
- Ghia, P;
- Lanasa, M C;
- Landgren, O;
- Rawstron, A C
Publication type:
journal article
A single-tube six-colour flow cytometry screening assay for the detection of minimal residual disease in myeloma.
Published in:
2007
By:
- de Tute, R. M.;
- Jack, A. S.;
- Child, J. A.;
- Morgan, G. J.;
- Owen, R. G.;
- Rawstron, A. C.
Publication type:
Letter
International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia.
Published in:
Leukemia (08876924), 2007, v. 21, n. 5, p. 956, doi. 10.1038/sj.leu.2404584
By:
- Rawstron, A. C.;
- Villamor, N.;
- Ritgen, M.;
- Böttcher, S.;
- Ghia, P.;
- Zehnder, J. L.;
- Lozanski, G.;
- Colomer, D.;
- Moreno, C.;
- Geuna, M.;
- Evans, P. A. S.;
- Natkunam, Y.;
- Coutre, S. E.;
- Avery, E. D.;
- Rassenti, L. Z.;
- Kipps, T. J.;
- Caligaris-Cappio, F.;
- Kneba, M.;
- Byrd, J. C.;
- Hallek, M. J.
Publication type:
Article
Flow cytometric protein expression profiling as a systematic approach for developing disease-specific assays: identification of a chronic lymphocytic leukaemia-specific assay for use in rituximab-containing regimens.
Published in:
Leukemia (08876924), 2006, v. 20, n. 12, p. 2102, doi. 10.1038/sj.leu.2404416
By:
- Rawstron, A. C.;
- de Tute, R.;
- Jack, A. S.;
- Hillmen, P.
Publication type:
Article
Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults.
Published in:
2006
By:
- De Tute, R.;
- Yuille, M.;
- Catovsky, D.;
- Houlston, R. S.;
- Hillmen, P.;
- Rawstron, A. C.
Publication type:
research
Translocation t(11;14) in multiple myeloma: Analysis of translocation breakpoints on der(11) and der(14) chromosomes suggests complex molecular mechanisms of recombination.
Published in:
Genes, Chromosomes & Cancer, 2004, v. 39, n. 2, p. 151, doi. 10.1002/gcc.10304
By:
- James A. L. Fenton;
- Guy Pratt;
- Dominic G. Rothwell;
- Andy C. Rawstron;
- Gareth J. Morgan
Publication type:
Article
Isotype class switching and the pathogenenesis of multiple myeloma.
Published in:
Hematological Oncology, 2002, v. 20, n. 2, p. 75, doi. 10.1002/hon.688
By:
- Fenton, J. A. L.;
- Pratt, G.;
- Rawstron, A. C.;
- Morgan, G. J.
Publication type:
Article
Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests.
Published in:
2000
By:
- Davies, F. E.;
- Rawstron, A. C.;
- Pratt, G.;
- Coupe, R.;
- Clarke, D.;
- Lubenko, A.;
- Short, K.;
- Perren, T. J.;
- Selby, P. J.;
- Maclennan, S.;
- Major, K.;
- Woodhead, V.;
- Robinson, F.;
- Child, J. A.;
- Smith, G. M.;
- Johnson, P. W. M.;
- Morgan, G. J.;
- Johnson, P W
Publication type:
journal article
Liposomal daunorubicin: in vitro and in vivo efficacy in multiple myeloma.
Published in:
1998
By:
- Pratt, G.;
- Wiles, M. E.;
- Rawstron, A. C.;
- Davies, F. E.;
- Fenton, J. A. L.;
- Proffitt, J. A.;
- Child, J. A.;
- Smith, G. M.;
- Morgan, G. J.;
- Fenton, J A
Publication type:
journal article
Defining IgM multiple myeloma.
Published in:
American Journal of Hematology, 2011, v. 86, n. 8, p. 717, doi. 10.1002/ajh.22061
By:
- Owen, Roger G;
- Feyler, Sylvia;
- O'Connor, Sheila JM;
- Bond, Lee R;
- de Tute, Ruth M;
- Rawstron, Andy C
Publication type:
Article
Predicting Severe Infection and Effects of Hypogammaglobulinemia During Therapy With Rituximab in Rheumatic and Musculoskeletal Diseases.
Published in:
Arthritis & Rheumatology, 2019, v. 71, n. 11, p. 1812, doi. 10.1002/art.40937
By:
- Md Yusof, Md Yuzaiful;
- Vital, Edward M.;
- McElvenny, Damien M.;
- Hensor, Elizabeth M. A.;
- Das, Sudipto;
- Dass, Shouvik;
- Rawstron, Andy C.;
- Buch, Maya H.;
- Emery, Paul;
- Savic, Sinisa
Publication type:
Article
Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop.
Published in:
British Journal of Haematology, 2013, v. 160, n. 2, p. 171, doi. 10.1111/bjh.12102
By:
- Owen, Roger G.;
- Kyle, Robert A.;
- Stone, Marvin J.;
- Rawstron, Andy C.;
- Leblond, Veronique;
- Merlini, Giampaolo;
- Garcia‐Sanz, Ramon;
- Ocio, Enrique M.;
- Morra, Enrica;
- Morel, Pierre;
- Anderson, Kenneth C.;
- Patterson, Christopher J.;
- Munshi, Nikhil C.;
- Tedeschi, Alessandra;
- Joshua, Douglas E.;
- Kastritis, Efstathios;
- Terpos, Evangelos;
- Ghobrial, Irene M.;
- Leleu, Xavier;
- Gertz, Morie A.
Publication type:
Article
Translocation t(14;16) in IgM multiple myeloma.
Published in:
British Journal of Haematology, 2011, v. 155, n. 3, p. 402, doi. 10.1111/j.1365-2141.2011.08687.x
By:
- Owen, Roger G.;
- O'Connor, Sheila J. M.;
- Bond, Lee R;
- de Tute, Ruth M;
- Rawstron, Andy C.
Publication type:
Article
A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia.
Published in:
British Journal of Haematology, 2011, v. 152, n. 5, p. 570, doi. 10.1111/j.1365-2141.2010.08317.x
By:
- Hillmen, Peter;
- Cohen, Dena R.;
- Cocks, Kim;
- Pettitt, Andrew;
- Sayala, Hazem A.;
- Rawstron, Andy C.;
- Kennedy, Daniel B.;
- Fegan, Christopher;
- Milligan, Don W.;
- Radford, John;
- Mercieca, Jane;
- Dearden, Claire;
- Ezekwisili, Raphael;
- Smith, Alexandra F.;
- Brown, Julia;
- Booth, Gillian A.;
- Varghese, Abraham M.;
- Pocock, Christopher
Publication type:
Article
Extramedullary plasmacytoma are characterized by a 'myeloma-like' immunophenotype and genotype and occult bone marrow involvement.
Published in:
British Journal of Haematology, 2010, v. 151, n. 5, p. 525, doi. 10.1111/j.1365-2141.2010.08386.x
By:
- Boll, Maayke;
- Parkins, Elizabeth;
- O'Connor, Sheila J. M.;
- Rawstron, Andy C.;
- Owen, Roger G.
Publication type:
Article
IgM myeloma: a rare entity characterized by a CD20−CD56−CD117− immunophenotype and the t(11;14).
Published in:
British Journal of Haematology, 2008, v. 140, n. 5, p. 547, doi. 10.1111/j.1365-2141.2007.06969.x
By:
- Feyler, Sylvia;
- O'Connor, Sheila J. M.;
- Rawstron, Andy C.;
- Subash, Chezhian;
- Ross, Fiona M.;
- Pratt, Guy;
- Drayson, Mark T.;
- Ashcroft, John;
- Cook, Gordon;
- Owen, Roger G.
Publication type:
Article
The biological and clinical relationship between CD5+23+ monoclonal B-cell lymphocytosis and chronic lymphocytic leukaemia.
Published in:
British Journal of Haematology, 2007, v. 139, n. 5, p. 724, doi. 10.1111/j.1365-2141.2007.06863.x
By:
- Rawstron, Andy C.;
- Bennett, Fiona;
- Hillmen, Peter
Publication type:
Article
Outreach monitoring service for patients with indolent B-cell and plasma cell disorders: a UK experience.
Published in:
British Journal of Haematology, 2007, v. 139, n. 5, p. 845, doi. 10.1111/j.1365-2141.2007.06864.x
By:
- Rawstron, Andy C.;
- Jones, Richard A.;
- Ferguson, Carol;
- Hughes, Geraint;
- Selby, Pam;
- Reid, Carol;
- Dalal, Surita;
- Howard, Martin;
- Smith, Graeme;
- Hillmen, Peter;
- Owen, Roger G.;
- Jack, Andrew S.
Publication type:
Article
Overview of monoclonal B-cell lymphocytosis.
Published in:
British Journal of Haematology, 2007, v. 139, n. 5, p. 701, doi. 10.1111/j.1365-2141.2007.06865.x
By:
- Marti, Gerald;
- Abbasi, Fatima;
- Raveche, Elizabeth;
- Rawstron, Andy C.;
- Ghia, Paolo;
- Aurran, Therese;
- Caporaso, Neil;
- Shim, Youn K.;
- Vogt, Robert F.
Publication type:
Article
Cyclooxygenase-2 (COX-2) in multiple myeloma: prognostic factor or therapeutic target?
Published in:
British Journal of Haematology, 2007, v. 136, n. 1, p. 163, doi. 10.1111/j.1365-2141.2006.06376.x
By:
- Owen, Roger G.;
- Im Fan;
- O'Connor, Sheila J. M.;
- Rollett, Rebecca A.;
- Child, J. Anthony;
- Davies, Faith E.;
- Rawstron, Andy C.
Publication type:
Article
MBL and MoBL – Response to Ziegler-Heitbrock.
Published in:
2005
By:
- Marti, Gerald E.;
- Rawstron, Andy C.;
- Ghia, Paolo;
- Hillmen, Peter;
- Houlston, Richard S.;
- Kay, Neil;
- Schleinitz, Thérëse Aurran;
- Caporaso, Neil
Publication type:
Letter
Diagnostic criteria for monoclonal B-cell lymphocytosis.
Published in:
British Journal of Haematology, 2005, v. 130, n. 3, p. 325, doi. 10.1111/j.1365-2141.2005.05550.x
By:
- Marti, Gerald E.;
- Rawstron, Andy C.;
- Ghia, Paolo;
- Hillmen, Peter;
- Houlston, Richard S.;
- Kay, Neil;
- Schleinitz, Thérèse A.;
- Caporaso, Neil
Publication type:
Article
A molecular study of the t(4;14) in multiple myeloma.
Published in:
British Journal of Haematology, 2002, v. 118, n. 2, p. 514, doi. 10.1046/j.1365-2141.2002.03618.x
By:
- Sibley, Kathryn;
- Fenton, James A. L.;
- Dring, Ann M.;
- Ashcroft, Andrew J.;
- Rawstron, Andrew C.;
- Morgan, Gareth J.
Publication type:
Article
Analysis of CD34+ cell subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34+ cell dose, but steady state levels do not correlate with bone marrow reserve.
Published in:
British Journal of Haematology, 2001, v. 114, n. 4, p. 937, doi. 10.1046/j.1365-2141.2001.03027.x
By:
- Pratt, G.;
- Rawstron, A. C.;
- English, A. E.;
- Johnson, R. J.;
- Jack, A. S.;
- Morgan, G. J.;
- Smith, G. M.
Publication type:
Article
In multiple myeloma, only a single stage of neoplastic plasma cell differentiation can be identified by VLA-5 and CD45 expression.
Published in:
British Journal of Haematology, 2001, v. 113, n. 3, p. 794, doi. 10.1046/j.1365-2141.2001.02730.x
By:
- Rawstron, A. C.;
- Barrans, S. L.;
- Blythe, D.;
- English, A.;
- Richards, S. J.;
- Fenton, J. A. L.;
- Davies, F. E.;
- Child, J. A.;
- Jack, A. S.;
- Morgan, G. J.
Publication type:
Article
The impact of attaining a minimal disease state after high-dose melphalan and autologous transplantation for multiple myeloma.
Published in:
British Journal of Haematology, 2001, v. 112, n. 3, p. 814, doi. 10.1046/j.1365-2141.2001.02530.x
By:
- Davies, Faith E.;
- Forsyth, Peter D.;
- Rawstron, Andrew C.;
- Owen, Roger G.;
- Pratt, Guy;
- Evans, Paul A. S.;
- Richards, Stephen J.;
- Drayson, Mark;
- Smith, Graeme M.;
- Selby, Peter J.;
- Child, J. Anthony;
- Morgan, Gareth J.
Publication type:
Article
Insertional events as well as translocations may arise during aberrant immunoglobulin switch recombination in a patient with multiple myeloma.
Published in:
British Journal of Haematology, 2001, v. 112, n. 2, p. 388, doi. 10.1046/j.1365-2141.2001.02588.x
By:
- Pratt, G.;
- Fenton, J. A. L.;
- Davies, F. E.;
- Rawstron, A. C.;
- Richards, S. J.;
- Collins, J. E.;
- Owen, R. G.;
- Jack, A. S.;
- Smith, G. M.;
- Morgan, G. J.
Publication type:
Article
Interleukin 6, tumour necrosis factor α and lymphotoxin α polymorphisms in monoclonal gammopathy of uncertain significance and multiple myeloma.
Published in:
British Journal of Haematology, 2001, v. 112, n. 1, p. 249, doi. 10.1046/j.1365-2141.2001.02497-2a.x
By:
- Dring, Ann M.;
- Davies, Faith E.;
- Rollinson, Sara J.;
- Roddam, Philippa L.;
- Rawstron, Andrew C.;
- Child, J. Anthony;
- Jack, Andrew S.;
- Morgan, Gareth J.
Publication type:
Article
Controversies surrounding the clonogenic origin of multiple myeloma.
Published in:
British Journal of Haematology, 2000, v. 110, n. 1, p. 240, doi. 10.1046/j.1365-2141.2000.02072-6.x
By:
- Davies, Faith E.;
- Rawstron, Andrew C.;
- Owen, Roger G.;
- Morgan, Gareth J.
Publication type:
Article
Assessment of ibrutinib plus rituximab in front-line CLL (FLAIR trial): study protocol for a phase III randomised controlled trial.
Published in:
2017
By:
- Collett, Laura;
- Howard, Dena R.;
- Munir, Talha;
- McParland, Lucy;
- Oughton, Jamie B.;
- Rawstron, Andy C.;
- Hockaday, Anna;
- Dimbleby, Claire;
- Phillips, David;
- McMahon, Kathryn;
- Hulme, Claire;
- Allsup, David;
- Bloor, Adrian;
- Hillmen, Peter
Publication type:
journal article
GA101 (obinutuzumab) monocLonal Antibody as Consolidation Therapy In CLL (GALACTIC) trial: study protocol for a phase II/III randomised controlled trial.
Published in:
2017
By:
- Oughton, Jamie B.;
- Collett, Laura;
- Howard, Dena R.;
- Hockaday, Anna;
- Munir, Talha;
- McMahon, Kathryn;
- McParland, Lucy;
- Dimbleby, Claire;
- Phillips, David;
- Rawstron, Andy C.;
- Hillmen, Peter
Publication type:
journal article
Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: study protocol for a phase II randomised controlled trial.
Published in:
2016
By:
- Howard, Dena R.;
- Munir, Talha;
- Hockaday, Anna;
- Rawstron, Andy C.;
- Collett, Laura;
- Oughton, Jamie B.;
- Allsup, David;
- Bloor, Adrian;
- Phillips, David;
- Hillmen, Peter
Publication type:
journal article
Ibrutinib induces chromatin reorganisation of chronic lymphocytic leukaemia cells.
Published in:
Oncogenesis, 2019, v. 8, n. 5, p. N.PAG, doi. 10.1038/s41389-019-0142-2
By:
- Holmes, Katie B.;
- Sadreev, Ildar I.;
- Rawstron, Andy C.;
- Munir, Tal;
- Westhead, David R.;
- Hillmen, Peter;
- Lefevre, Pascal F.
Publication type:
Article

Found: 53